Our scientists and doctors developed a combination of medicines to deprive cancer of the nutrients it needs to grow and spread

*Care Oncology U.S. works in coordination with the SEEK Group and Care Oncology Clinic of London, UK

*COC Protocol Doubles Patient Survival

Treatment now available in the U.S.

Our FDA Approved Medications are cost effective, safe, well tolerated and well understood

Upcoming Cancer Trials

If you are interested in the COC Cancer Protocol or upcoming Cancer Trials - Join Now

Get COC Protocol and Trial Information

I just want to ask a question

Scientists have spent in excess of 5 years working on the best combination of medicines to use to target the metabolic pathways of cancer that are safe and work in harmony with standard of care cancer treatments. This involved cellular and animal experiments in the laboratory as well as literature research of existing medicines looking at the way they work and their safety profile as well as those that have shown significant benefit in a large number of humans with cancer or as a preventative to cancer.

The Telegraph

The Times

Pharmaceutical Technology

Express

The Independent

The Daily Mail

COC Protocol Glioblastoma Brain Cancer Treatment Results

GLIOBLASTOMA SURVIVABILITY DOUBLES WITH COC PHARMACEUTICAL COMPOSITION

Care Oncology’s patented COC Protocol™ has proven to increase the survival in Glioblastoma patients when used in combination with standard-of-care*.

A clinical trial performed in the U.K., comprised of a 95-patient cohort, resulted in a median overall survival of 27 months when the COC Protocol was used in addition to standard-of-care. Compared to median overall survival of 15.6 months¹ and 14.8 months² with standard-of-care alone.

See long term Glioblastoma survivors in the news who use the COC Protocol:

Patient 1 now 4 years out post diagnosis – Featured in The Telegraph

Patient 2 now 3 years out post diagnosis – Featured in Daily Mail

Read More…

The Care Oncology Clinic designed the COC Protocol to complement and enhance standard-of-care therapy.

Our 4-year study has shown that our adjunctive program may enhance the overall effect of conventional cancer treatment.

All of the medications used in the COC Protocol are well understood and have few side effects.

If you are interested in the COC Cancer Protocol or upcoming Cancer Trials – Join Now by filling out this form.

If you are interested in hearing more about our study or cancer treatment please call 800-392-1353

Further details about the study being undertaken can be found by visiting www.clinicaltrials.gov

COC Protocol Cancer PatientIt took me quite a while to come across this clinic and am so grateful that I have now found them.

– Lucy O’Donnell – Breast Cancer Patient

“Study finds diabetes drug Metformin inhibits progression of pancreatic cancer”

– Harvard Medical School

“The question is – why wait to add in the COC drugs to your cancer treatment when it may potentially help whilst doing very little harm?”

-Joanna L. – Breast Cancer Patient

“Antibiotics eradicate cancer stem cells across multiple tumor types”

– University of Manchester

“Statins could halve the risk of dying from cancer”

– Stanford University School of Medicine

“Widely Prescribed Oral Diabetes Drug Leads to Dramatic Breakthrough Cancer Treatment”

– Nagourney Cancer Institute